6
Participants
Start Date
July 31, 2015
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
ticagrelor
ticagrelor 90 mg bid
aspirin
aspirin 81 mg daily
New York University School of Medicine, New York
Sinai Hospital of Baltimore, Baltimore
Central Georgia Heart Center, Macon
University of Florida College of Medicine - Jacksonville, Jacksonville
Florida Hospital Orthopaedic Institute and Fracture Care Center, Orlando
University of South Florida, Tampa
University of South Alabama Health System, Mobile
University of Kentucky, Lexington
VA Medical Center - Cleveland Louis Stokes, Cleveland
MetroHealth Medical Center, Cleveland
Cleveland Clinic, Cleveland
Cincinnati VA Medical Center, Cincinnati
Miami Valley Hospital, Dayton
Saint Vincent Medical Group, Indianapolis
McLaren Macomb, Mount Clemens
Henry Ford Hospital, Detroit
McLaren Bay Region, Bay City
University of Minnesota, Minneapolis
Arkansas Site Management Service, LLC, Little Rock
Oklahoma Heart Institute, Tulsa
VA North Texas Health Care System, Dallas
University of Texas Health Science Center at Houston, Houston
Oregon Health and Science University, Portland
Overlake Hospital Medical Center, Bellevue
Collaborators (1)
AstraZeneca
INDUSTRY
The Cleveland Clinic
OTHER